Glycopyrrolate Injection
Product Images NDC 71872-7307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

7307.pdp (7307)

7307.pdp (7307)
Glycopyrrolate Injection, USP is available in a 0.2 mg/mL concentration in a 5 mL multiple dose vial. This medication is not suitable for use in newborns and contains Benzyl Alcohol as a preservative. It is administered via intramuscular or intravenous route. The solution is prepared using Water for Injection, USP, and adjusted to a pH of 0.9% with hydrochloric acid and/or sodium hydroxide. The usual dosage information can be found in the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). This product is manufactured for Xiromed, LLC in Florham Park, NJ and distributed by Medical Purchasing Solutions in Scottsdale, AZ. More information can be found on medicalpurchasingsolutions.com.*
FDA Label Image

Glyc.pdp (Glycopyrrolate Spl 5ml Container Label)

Glyc.pdp (Glycopyrrolate Spl 5ml Container Label)
FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.